1. Home
  2. SANM vs RGC Comparison

SANM vs RGC Comparison

Compare SANM & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sanmina Corporation

SANM

Sanmina Corporation

HOLD

Current Price

$150.70

Market Cap

8.4B

Sector

Technology

ML Signal

HOLD

Logo Regencell Bioscience Holdings Limited

RGC

Regencell Bioscience Holdings Limited

HOLD

Current Price

$21.22

Market Cap

9.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SANM
RGC
Founded
1980
2014
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Electrical Products
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.4B
9.8B
IPO Year
1993
2021

Fundamental Metrics

Financial Performance
Metric
SANM
RGC
Price
$150.70
$21.22
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$120.00
N/A
AVG Volume (30 Days)
606.1K
328.1K
Earning Date
01-26-2026
10-24-2025
Dividend Yield
N/A
N/A
EPS Growth
14.07
N/A
EPS
4.46
N/A
Revenue
$8,128,382,000.00
N/A
Revenue This Year
$75.74
N/A
Revenue Next Year
$12.92
N/A
P/E Ratio
$33.65
N/A
Revenue Growth
7.40
N/A
52 Week Low
$63.67
$0.09
52 Week High
$178.39
$83.60

Technical Indicators

Market Signals
Indicator
SANM
RGC
Relative Strength Index (RSI) 46.51 58.10
Support Level $150.94 $19.80
Resistance Level $155.44 $25.50
Average True Range (ATR) 7.03 2.61
MACD -0.77 0.33
Stochastic Oscillator 26.91 48.64

Price Performance

Historical Comparison
SANM
RGC

About SANM Sanmina Corporation

Sanmina Corp is a provider of integrated manufacturing solutions, components, and after-market services to original equipment manufacturers in the communications networks, storage, industrial, defense, and aerospace end markets. The operations are managed as two businesses: Integrated Manufacturing Solutions, which consists of printed circuit board assembly and represents a majority of the firm's revenue; and Components, Products, and Services, which includes interconnect systems and mechanical systems. The firm generates revenue mainly in the United States, China, and Mexico, but has a presence around the world.

About RGC Regencell Bioscience Holdings Limited

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Share on Social Networks: